Literature DB >> 9409097

Symptom prevalence in the last week of life.

C Conill1, E Verger, I Henríquez, N Saiz, M Espier, F Lugo, A Garrigos.   

Abstract

Palliative care is the management of patients with progressive, far-advanced disease for whom the prognosis is limited and the focus of care is quality of life. During the last days of life, it is important to redefine the goals, as previously present symptoms may increase and new symptoms may appear. To assess these symptoms, 176 patients were evaluated. A questionnaire evaluated symptoms during the last week of life and compared these prevalences with those at the first evaluation. The patients comprised 121 men and 55 women. The mean age was 67.7 years. Metastases were present in 66.5% and were multiple in 52%. The most frequent symptoms at the end of life (> 50%) were anorexia, asthenia, dry mouth, confusion, and constipation. The majority of patients died at home (64.2%). We observed good control of "reversible" symptoms, but many symptoms were difficult to control at the end of life. Symptom assessment is important in this population.

Entities:  

Mesh:

Year:  1997        PMID: 9409097     DOI: 10.1016/s0885-3924(97)00263-7

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  24 in total

1.  Edmonton Regional Palliative Care Program: impact on patterns of terminal cancer care.

Authors:  E Bruera; C M Neumann; B Gagnon; C Brenneis; P Kneisler; P Selmser; J Hanson
Journal:  CMAJ       Date:  1999-08-10       Impact factor: 8.262

2.  Symptom experience in the last year of life among individuals with cancer.

Authors:  Ardith Z Doorenbos; Charles W Given; Barbara Given; Natalya Verbitsky
Journal:  J Pain Symptom Manage       Date:  2006-11       Impact factor: 3.612

3.  The epidemiology of pain during the last 2 years of life.

Authors:  Alexander K Smith; Irena Stijacic Cenzer; Sara J Knight; Kathleen A Puntillo; Eric Widera; Brie A Williams; W John Boscardin; Kenneth E Covinsky
Journal:  Ann Intern Med       Date:  2010-11-02       Impact factor: 25.391

4.  Identifying the Prevalence and Correlates of Caregiver-Reported Symptoms in Home Hospice Patients at the End of Life.

Authors:  Veerawat Phongtankuel; Jeanne A Teresi; Joseph P Eimicke; Jian X Kong; Ronald D Adelman; Holly G Prigerson; Sara J Czaja; Ariel Shalev; Ritchell Dignam; Rosemary Baughn; M Cary Reid
Journal:  J Palliat Med       Date:  2019-12-23       Impact factor: 2.947

5.  Advanced cancer patients' reported wishes at the end of life: a randomized controlled trial.

Authors:  Marvin O Delgado-Guay; Alfredo Rodriguez-Nunez; Vera De la Cruz; Susan Frisbee-Hume; Janet Williams; Jimin Wu; Diane Liu; Michael J Fisch; Eduardo Bruera
Journal:  Support Care Cancer       Date:  2016-05-10       Impact factor: 3.603

Review 6.  Hypnosis for Symptom Control in Cancer Patients at the End-of-Life: A Systematic Review.

Authors:  Guy H Montgomery; Madalina Sucala; Tessa Baum; Julie B Schnur
Journal:  Int J Clin Exp Hypn       Date:  2017 Jul-Sep

7.  Fatigue in cancer: a review of literature.

Authors:  Vijayakumar Narayanan; Cherian Koshy
Journal:  Indian J Palliat Care       Date:  2009-01

8.  Research participation by older adults at end of life: barriers and solutions.

Authors:  Melissa Lehan Mackin; Keela Herr; Kimberly Bergen-Jackson; Perry Fine; Chris Forcucci; Sara Sanders
Journal:  Res Gerontol Nurs       Date:  2009-04-30       Impact factor: 1.571

9.  A computer-assisted model for predicting probability of dying within 7 days of hospice admission in patients with terminal cancer.

Authors:  Jui-Kun Chiang; Yu-Hsiang Cheng; Malcolm Koo; Yee-Hsin Kao; Ching-Yu Chen
Journal:  Jpn J Clin Oncol       Date:  2010-01-22       Impact factor: 3.019

10.  A proposed prognostic 7-day survival formula for patients with terminal cancer.

Authors:  Jui-Kun Chiang; Ning-Sheng Lai; Mei-Huang Wang; Shi-Chi Chen; Yee-Hsin Kao
Journal:  BMC Public Health       Date:  2009-09-29       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.